New drug crisugabalin takes on pregabalin in fibromyalgia pain showdown
NCT ID NCT07196657
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two medications, pregabalin and a newer drug called crisugabalin, to see which works better for easing fibromyalgia pain. Over 1,100 adults with moderate to severe fibromyalgia will take one of the two drugs, and researchers will measure how many get at least 50% pain relief. The goal is to find a more effective treatment option for this chronic pain condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- pregabalin and crisugabalin
- What this could lead to
- If successful, this could point toward a more effective pain relief option for people with fibromyalgia.
- What could go wrong
- This is an early-stage comparison study, not a cure. The new drug may not work better than the existing one, and side effects are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIBROMYALGIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Tiantan Hospital, Beijing, Beijing 100070
RECRUITINGBeijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tape to tame Post-Surgery face swelling?
- Electric pulses on the wrist may tame colonoscopy pain
- Virtual reality may distract patients from pain and fear during anesthesia
- Could hidden sleep problems be worsening fibromyalgia?
- Could a gentle yoga practice turn down the Body's pain and inflammation?
- Can a 5-Pill opioid prescription match a 30-Pill one after hip surgery?